R. Parsons, Gary M. Woller, Giinther Neubauer, Frank Thomas Rothaemel, Barbara Zelle
{"title":"Health Care Policy Reform","authors":"R. Parsons, Gary M. Woller, Giinther Neubauer, Frank Thomas Rothaemel, Barbara Zelle","doi":"10.1300/J043v13n02_04","DOIUrl":null,"url":null,"abstract":"Abstract Microcomparison, or single-component analysis, of health care systems offers a potentially better basis for reform than traditional macrocomparison analysis of aggregate elements. Using ma-croanalysis, available evidence shows that Germany provides cheaper but more effective hospital care than the United States. To find the causes for this outcome, we developed a microanalytic model of hospital administrators' perceptions, financial ratios, medical outcomes, and pharmaceutical costs. However, only data on pharmaceutical costs were available, and these were similar in both countries. Our significant outcome was development of a microcomparative model that gives world medical care providers new criteria for analyzing and improving cost to care ratios.","PeriodicalId":79671,"journal":{"name":"Journal of hospital marketing","volume":"13 1","pages":"43 - 61"},"PeriodicalIF":0.0000,"publicationDate":"2000-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1300/J043v13n02_04","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of hospital marketing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1300/J043v13n02_04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Abstract Microcomparison, or single-component analysis, of health care systems offers a potentially better basis for reform than traditional macrocomparison analysis of aggregate elements. Using ma-croanalysis, available evidence shows that Germany provides cheaper but more effective hospital care than the United States. To find the causes for this outcome, we developed a microanalytic model of hospital administrators' perceptions, financial ratios, medical outcomes, and pharmaceutical costs. However, only data on pharmaceutical costs were available, and these were similar in both countries. Our significant outcome was development of a microcomparative model that gives world medical care providers new criteria for analyzing and improving cost to care ratios.